Clinical Trials Logo

Senile Purpura clinical trials

View clinical trials related to Senile Purpura.

Filter by:
  • None
  • Page 1

NCT ID: NCT05037604 Completed - Senile Purpura Clinical Trials

Factors Associated With Dermatoporosis

FAWD
Start date: August 1, 2018
Phase:
Study type: Observational

Dermatoporosis is a chronic syndrome of skin insufficiency or fragility. It is characterized by cutaneous atrophy, senile purpura and stellate pseudoscars. Dermatoporosis prevalence is 37% in ≥65 years. The objective was to determine factors associated with this diagnosis in >60 years old patients of the outpatient clinic in the Hospital Central "Dr. Ignacio Morones Prieto " San Luis Potosí, México. An observational, cross-sectional, descriptive, and analytical study was performed. Patients >60 years old were selected. A clinical history, clinical examination, and application of a validated diagnostic self-questionnaire were performed.

NCT ID: NCT03690375 Completed - Senile Purpura Clinical Trials

Broad Band Light for the Treatment and Prevention of Senile Purpura

Start date: August 27, 2018
Phase: N/A
Study type: Interventional

There will be five subjects over the age of 65, each with at least one ecchymotic lesion on each arm measuring at least one cm, and five control subjects under the age of 35, both who will be randomized to undergo 4 Sciton Broad Band Light (BBL) treatments on either their left or right arm one week apart. Subjects will fill out questionnaires, have pictures of their lower arms taken, and will be graded and measured by evaluators regarding the number and size of their ecchymoses as well as side effects such as blistering, pain, erythema, and swelling. One day after their 4th treatment on each arm, subjects will have biopsies done to be analyzed for changes in histology and gene expression. The subjects will follow up 1 month after their last treatments for final pictures of their lower arms and evaluations.

NCT ID: NCT01485367 Recruiting - Senile Purpura Clinical Trials

A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura

Start date: December 2011
Phase: Phase 2
Study type: Interventional

This is an open label 6 month pilot study for male and female participants over the age of 52 that desire treatment and prevention of senile purpura of the forearms. This study will be evaluating the effects of Adapalene 0.3% for the use in the treatment and prevention of senile purpura.